Barinthus Biotherapeutics plc. Quarterly Interest Expense in USD from Q3 2020 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Barinthus Biotherapeutics plc. quarterly/annual Interest Expense history and growth rate from Q3 2020 to Q1 2024.
  • Barinthus Biotherapeutics plc. Interest Expense for the quarter ending March 31, 2024 was $12K.
  • Barinthus Biotherapeutics plc. annual Interest Expense for 2023 was $28K, a 47.4% increase from 2022.
  • Barinthus Biotherapeutics plc. annual Interest Expense for 2022 was $19K, a 99.3% decline from 2021.
  • Barinthus Biotherapeutics plc. annual Interest Expense for 2021 was $2.67M, a 25.9% decline from 2020.
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $12K +$12K Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-13
Q1 2023 $0 -$74K -100% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-13
Q1 2022 $74K -$2.58M -97.2% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-12
Q1 2021 $2.65M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-11
Q3 2020 $969K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.